Neurobehavioural evidence for the involvement of the FMR1 gene in female carriers of fragile X syndrome

Neuroscience and Biobehavioral Reviews

Volumn 37, Issue 3, 2013, Pages 522-547

  Kraan, Claudine M ^a   Hocking, Darren R ^a   Bradshaw, John L ^a   Fielding, Joanne ^a   Cohen, Jonathan ^a,b   Georgiou Karistianis, Nellie ^a   Cornish, Kim M ^a  

^a MONASH UNIVERSITY   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

Author keywords

Executive function 33 ; Female 114 ; FMR1 mRNA 42 ; FMRP 33 ; FXS 29 ; Neurobehavioural 6 ; Neuromotor 44 ; Premutation 188 ; Visuospatial 33

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; MESSENGER RNA;

ANXIETY; ATTENTION DEFICIT DISORDER; BRAIN DEVELOPMENT; BRAIN FUNCTION; BRAIN SIZE; CEREBELLUM; CGG REPEAT; CHROMOSOME INACTIVATION; COGNITION; DEPTH PERCEPTION; DISEASE MODEL; EMOTION; EPIGENETICS; EXECUTIVE FUNCTION; FMR1 GENE; FRAGILE X PRIMARY OVARIAN INSUFFICIENCY; FRAGILE X SYNDROME; FRONTAL CORTEX; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC RISK; HETEROZYGOTE; HIPPOCAMPUS; HUMAN; INFERIOR FRONTAL GYRUS; MENOPAUSE; MENTAL TASK; MOTONEURON; NERVE CELL NETWORK; NERVE DEGENERATION; NEUROIMAGING; NEUROPSYCHIATRY; NONHUMAN; OVARY INSUFFICIENCY; PARIETAL CORTEX; PHENOTYPE; PREFRONTAL CORTEX; PREMOTOR CORTEX; PRIORITY JOURNAL; PROTEIN RNA BINDING; REVIEW; RISK ASSESSMENT; TRINUCLEOTIDE REPEAT; X CHROMOSOME;

ANIMALS; BEHAVIOR; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; GENE EXPRESSION REGULATION; HUMANS; MUTATION; PHENOTYPE;

EID: 84875078124     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2013.01.010     Document Type: Review

References (186)

1. Abbeduto L., Seltzer M.M., Shattuck P., Krauss M.W., Orsmond G., Murphy M.M. Psychological well-being and coping in mothers of youths with autism, down syndrome, or fragile X syndrome. American Journal of Mental Retardation 2004, 109(3):237-254.
2. Abitbol M., Menini C., Delezoide A.L., Rhyner T., Vekemans M., Mallet J. Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain. Nature Genetics 1993, 4(2):147-153.
3. Adams J.S., Adams P.E., Nguyen D., Brunberg J.A., Tassone F., Zhang W., et al. Volumetric brain changes in females with fragile X-associated tremor/ataxia syndrome (FXTAS). Neurology 2007, 69(9):851-859.
4. Adams P.E., Adams J.S., Nguyen D.V., Hessl D., Brunberg J.A., Tassone F., et al. Psychological symptoms correlate with reduced hippocampal volume in fragile X premutation carriers. American Journal of Medical Genetics. Part B. Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics 2010, 153B(3):775-785.
5. Aguilar D., Sigford K.E., Soontarapornchai K., Nguyen D.V., Adams P.E., Yuhas J.M., et al. A quantitative assessment of tremor and ataxia in FMR1 premutation carriers using CATSYS. American Journal of Medical Genetics. Part A 2008, 146A(5):629-635.
6. Allen E.G., He W., Yadav-Shah M., Sherman S.L. A study of the distributional characteristics of FMR1 transcript levels in 238 individuals. Human Genetics 2004, 114(5):439-447.
7. Allen E.G., Sullivan A.K., Marcus M., Small C., Dominguez C., Epstein M.P., et al. Examination of reproductive aging milestones among women who carry the FMR1 premutation. Human Reproduction 2007, 22(8):2142-2152.
8. Allen E.G., Hunter J.E., Rusin M., Juncos J., Novak G., Hamilton D., et al. Neuropsychological findings from older premutation carrier males and their noncarrier siblings from families with fragile X syndrome. Neuropsychology 2011, 25(3):404-411.
9. Allen E.G., Juncos J., Letz R., Rusin M., Hamilton D., Novak G., et al. Detection of early FXTAS motor symptoms using the CATSYS computerised neuromotor test battery. Journal of Medical Genetics 2008, 45(5):290-297.
10. American College of Gynecologists Committee on G. ACOG Committee Opinion No. 469: carrier screening for fragile X syndrome. Obstetrics and Gynecology 2010, 116(4):1008-1010.
11. Arocena D.G., Iwahashi C.K., Won N., Beilina A., Ludwig A.L., Tassone F., et al. Induction of inclusion formation and disruption of lamin A/C structure by premutation CGG-repeat RNA in human cultured neural cells. Human Molecular Genetics 2005, 14(23):3661-3671.
12. Audoin B., Ibarrola D., Au Duong M.V., Pelletier J., Confort-Gouny S., Malikova I., et al. Functional MRI study of PASAT in normal subjects. Magma 2005, 18(2):96-102.
13. Auerbach B.D., Bear M.F. Loss of the fragile X mental retardation protein decouples metabotropic glutamate receptor dependent priming of long-term potentiation from protein synthesis. Journal of Neurophysiology 2010, 104(2):1047-1051.
14. Aziz M., Stathopulu E., Callias M., Taylor C., Turk J., Oostra B., et al. Clinical features of boys with fragile X premutations and intermediate alleles. American Journal of Medical Genetics. Part B. Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics 2003, 121B(1):119-127.
15. Bear M.F. Therapeutic implications of the mGluR theory of fragile X mental retardation. Genes, Brain, & Behavior 2005, 4(6):393-398.
16. Berga S., Naftolin F. Neuroendocrine control of ovulation. Gynecological Endocrinology 2012, 28(Suppl. 1):9-13.
17. Berry-Kravis E., Abrams L., Coffey S.M., Hall D.A., Greco C., Gane L.W., et al. Fragile X-associated tremor/ataxia syndrome: clinical features, genetics, and testing guidelines. Movement Disorders 2007, 22(14):2018-2030. quiz 2140.
18. Berry-Kravis E., Lewin F., Wuu J., Leehey M., Hagerman R., Hagerman P., et al. Tremor and ataxia in fragile X premutation carriers: blinded videotape study. Annals of Neurology 2003, 53(5):616-623.
19. Berry-Kravis E., Potanos K., Weinberg D., Zhou L., Goetz C.G. Fragile X-associated tremor/ataxia syndrome in sisters related to X-inactivation. Annals of Neurology 2005, 57(1):144-147.
20. Borthwell R.M., Hunsaker M.R., Willemson R., Berman R.F. Spatiotemporal processing deficits in female CGG KI mice modelling the fragile X premutation. Behavioural Brain Research 2012, 233(1):29-34.
21. Bourgeois J.A., Coffey S.M., Rivera S.M., Hessl D., Gane L.W., Tassone F., et al. A review of fragile X premutation disorders: expanding the psychiatric perspective. Journal of Clinical Psychiatry 2009, 70(6):852-862.
22. Bourgeois J.A., Seritan A.L., Casillas E.M., Hessl D., Schneider A., Yang Y., et al. Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers. Journal of Clinical Psychiatry 2011, 72(2):175-182.
23. Brega A.G., Goodrich G., Bennett R.E., Hessl D., Engle K., Leehey M.A., et al. The primary cognitive deficit among males with fragile X-associated tremor/ataxia syndrome (FXTAS) is a dysexecutive syndrome. Journal of Clinical & Experimental Neuropsychology: Official Journal of the International Neuropsychological Society 2008, 30(8):853-869.
24. Brouwer J.R., Willemsen R., Oostra B.A. The FMR1 gene and fragile X-associated tremor/ataxia syndrome. American Journal of Medical Genetics. Part B. Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics 2009, 150B(6):782-798.
25. Brunberg J.A., Jacquemont S., Hagerman R.J., Berry-Kravis E.M., Grigsby J., Leehey M.A., et al. Fragile X premutation carriers: characteristic MR imaging findings of adult male patients with progressive cerebellar and cognitive dysfunction. AJNR: American Journal of Neuroradiology 2002, 23(10):1757-1766.
26. Callan M.A., Zarnescu D.C. Heads-up: new roles for the fragile X mental retardation protein in neural stem and progenitor cells. Genesis: The Journal of Genetics & Development 2011, 49(6):424-440.
27. Castellanos F.X., Sonuga-Barke E.J.S., Milham M.P., Tannock R. Characterizing cognition in ADHD: beyond executive dysfunction. Trends in Cognitive Sciences 2006, 10(3):117-123.
28. Chang M., Decaro J., Zheng M., Gearing M., Shubeck L., Sherman S.L., et al. Ovarian histopathological and ubiquitin-immunophenotypic features in fragile X-associated primary ovarian insufficiency: a study of five cases and selected controls. Histopathology 2011, 59:1006-1029.
29. Chen Y., Tassone F., Berman R.F., Hagerman P.J., Hagerman R.J., Willemsen R., et al. Murine hippocampal neurons expressing Fmr1 gene premutations show early developmental deficits and late degeneration. Human Molecular Genetics 2010, 19(1):196-208.
30. Chonchaiya W., Au J., Schneider A., Hessl D., Harris S.W., Laird M., et al. Increased prevalence of seizures in boys who were probands with the FMR1 premutation and co-morbid autism spectrum disorder. Human Genetics 2012, 131(4):581-589.
31. Chonchaiya W., Nguyen D.V., Au J., Campos L., Berry-Kravis E.M., Lohse K., et al. Clinical involvement in daughters of men with fragile X-associated tremor ataxia syndrome. Clinical Genetics 2010, 78(1):38-46.
32. Coffey S.M., Cook K., Tartaglia N., Tassone F., Nguyen D.V., Pan R., et al. Expanded clinical phenotype of women with the FMR1 premutation. American Journal of Medical Genetics. Part A 2008, 146A(8):1009-1016.
33. Cohen S., Masyn K., Adams J., Hessl D., Rivera S., Tassone F., et al. Molecular and imaging correlates of the fragile X-associated tremor/ataxia syndrome. Neurology 2006, 67(8):1426-1431.
34. Comery T.A., Harris J.B., Willems P.J., Oostra B.A., Irwin S.A., Weiler I.J., et al. Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proceedings of the National Academy of Sciences of the United States of America 1997, 94(10):5401-5404.
35. Cornish, Hocking D.R., Moss S.A., Kogan C.S. Selective executive markers of at-risk profiles associated with the fragile X premutation. Neurology 2011, 77(7):618-622.
36. Cornish, Kogan C., Turk J., Manly T., James N., Mills A., et al. The emerging fragile X premutation phenotype: evidence from the domain of social cognition. Brain & Cognition 2005, 57(1):53-60.
37. Cornish, Kogan C.S., Li L., Turk J., Jacquemont S., Hagerman R.J. Lifespan changes in working memory in fragile X premutation males. Brain & Cognition 2009, 69(3):551-558.
38. Cornish, Turk J., Hagerman R. The fragile X continuum: new advances and perspectives. Journal of Intellectual Disability Research 2008, 52(Pt 6):469L 482.
39. Cornish K., Li L., Kogan C.S., Jacquemont S., Turk J., Dalton A., et al. Age-dependent cognitive changes in carriers of the fragile X syndrome. Cortex 2008, 44(6):628-636.
40. Cunningham C.L., Martinez Cerdeno V., Navarro Porras E., Prakash A.N., Angelastro J.M., Willemsen R., et al. Premutation CGG-repeat expansion of the Fmr1 gene impairs mouse neocortical development. Human Molecular Genetics 2011, 20(1):64-79.
41. D'Hulst C., Heulens I., Brouwer J.R., Willemsen R., De Geest N., Reeve S.P., et al. Expression of the GABAergic system in animal models for fragile X syndrome and fragile X associated tremor/ataxia syndrome (FXTAS). Brain Research 2009, 1253:176-183.
42. De Caro J.J., Dominguez C., Sherman S.L. Reproductive health of adolescent girls who carry the FMR1 premutation: expected phenotype based on current knowledge of fragile x-associated primary ovarian insufficiency. Annals of the New York Academy of Sciences 2008, 1135:99-111.
43. Diep A.A., Hunsaker M.R., Kwock R., Kyoungmi K., Willemsen R., Berman R.F. Female CGG knock-in mice modeling the fragile X premutation are impaired on a skilled forelimb reaching task. Neurobiology of Learning & Memory 2011, 97(2):229-234.
44. Farzin F., Perry H., Hessl D., Loesch D., Cohen J., Bacalman S., et al. Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation. Journal of Developmental & Behavioral Pediatrics 2006, 27(Suppl. 2):S137-S144.
45. Fatemi S.H., Folsom T.D. The role of fragile X mental retardation protein in major mental disorders. Neuropharmacology 2011, 60(7/8):1221-1226.
46. Fatemi S.H., Folsom T.D., Kneeland R.E., Liesch S.B. Metabotropic glutamate receptor 5 upregulation in children with autism is associated with underexpression of both Fragile X mental retardation protein and GABAA receptor beta 3 in adults with autism. Anatomical Record (Hoboken, N.J.: 2007) 2011, 294(10):1635-1645.
47. Finucane B., Abrams L., Cronister A., Archibald A., Bennett R., McConkie-Rosell A. Genetic counseling and testing for FMR1 gene mutations: practice guidelines of the National Society of Genetic Counselors. Journal of Genetic Counseling 2012, 1-9. epub ahead of print.
48. Fierro B., Giglia G., Palermo A., Pecoraro C., Scalia S., Brighina F. Modulatory effects of 1Hz rTMS over the cerebellum on motor cortex excitability. Experimental Brain Research 2007, 176(3):440-447.
49. Franke P., Leboyer M., Gansicke M., Weiffenbach O., Biancalana V., Cornillet-Lefebre P., et al. Genotype-phenotype relationship in female carriers of the premutation and full mutation of FMR-1. Psychiatry Research 1998, 80(2):113-127.
50. Galvez R., Greenough W.T. Sequence of abnormal dendritic spine development in primary somatosensory cortex of a mouse model of the fragile X mental retardation syndrome. American Journal of Medical Genetics. Part A 2005, 135(2):155-160.
51. Garcia-Alegria E., Ibanez B., Minguez M., Poch M., Valiente A., Sanz-Parra A., et al. Analysis of FMR1 gene expression in female premutation carriers using robust segmented linear regression models. Rna: A Publication of the Rna Society 2007, 13(5):756-762.
52. Garcia-Arocena D., Yang J.E., Brouwer J.R., Tassone F., Iwahashi C., Berry-Kravis E.M., et al. Fibroblast phenotype in male carriers of FMR1 premutation alleles. Human Molecular Genetics 2010, 19(2):299-312.
53. Glickstein M. How are visual areas of the brain connected to motor areas for the sensory guidance of movement?. Trends in Neurosciences 2000, 23(12):613-617.
54. Godler D.E., Tassone F., Loesch D.Z., Taylor A.K., Gehling F., Hagerman R.J., et al. Methylation of novel markers of fragile X alleles is inversely correlated with FMRP expression and FMR1 activation ratio. Human Molecular Genetics 2010, 19(8):1618-1632.
55. Godler D.E., Slater H.R., Bui Q.M., et al. Fragile X mental retardation 1 (FMR1) intron 1 methylation in blood predicts verbal cognitive impairment in female carriers of expanded FMR1 alleles: evidence from a pilot study. Clinical Chemistry 2012, 58:590-598.
56. Goodrich-Hunsaker N.J., Wong L.M., McLennan Y., Srivastava S., Tassone F., Harvey D., et al. Young adult female fragile X premutation carriers show age- and genetically-modulated cognitive impairments. Brain & Cognition 2011, 75(3):255-260.
57. Goodrich-Hunsaker N.J., Wong L.M., McLennan Y., Tassone F., Harvey D., Rivera S., et al. Enhanced manual and oral motor reaction time in young adult female fragile X premutation carriers. Journal of the International Neuropsychological Society 2011, 17:1-5.
58. Greco C.M., Berman R.F., Martin R.M., Tassone F., Schwartz P.H., Chang A., et al. Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain 2006, 129(Pt 1):243L 255.
59. Greco C.M., Hagerman R.J., Tassone F., Chudley A.E., Del Bigio M.R., Jacquemont S., et al. Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. Brain 2002, 125(Pt 8):1760L 1771.
60. Grigsby J., Brega A.G., Engle K., Leehey M.A., Hagerman R.J., Tassone F., et al. Cognitive profile of fragile X premutation carriers with and without fragile X-associated tremor/ataxia syndrome. Neuropsychology 2008, 22(1):48-60.
61. Gross C., Yao X., Pong D.L., Jeromin A., Bassell G.J. Fragile X mental retardation protein regulates protein expression and mRNA translation of the potassium channel Kv4.2. Journal of Neuroscience 2011, 31(15):5693-5698.
62. Hagerman P., Hagerman R. Fragile X-associated tremor/ataxia syndrome (FXTAS). Mental Retardation & Developmental Disabilities Research Reviews 2004, 10(1):25-30.
63. Hagerman P.J., Hagerman R.J. The fragile-X premutation: a maturing perspective. American Journal of Human Genetics 2004, 74(5):805-816.
64. Hagerman R.J., Leavitt B.R., Farzin F., Jacquemont S., Greco C.M., Brunberg J.A., et al. Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation. American Journal of Human Genetics 2004, 74(5):1051-1056.
65. Hagerman R.J., Leehey M., Heinrichs W., Tassone F., Wilson R., Hills J., et al. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 2001, 57(1):127-130.
66. Hall D.A., Berry-Kravis E., Tassone F., Zerbe G., Ouyang B., Leehey M. FMR1 gray-zone alleles: association with Parkinson's disease in women?. Movement Disorders 2011, 26(10):1900-1906.
67. Hall S.S., Burns D.D., Reiss A.L. Modeling family dynamics in children with fragile x syndrome. Journal of Abnormal Child Psychology 2007, 35(1):29-42.
68. Hashem V., Galloway J.N., Mori M., et al. Ectopic expression of CGG containing mRNA is neurotoxic in mammals. Human Molecular Genetics 2009, 18:2443-2451.
69. Hashimoto R.-I., Backer K.C., Tassone F., Hagerman R.J., Rivera S.M. An fMRI study of the prefrontal activity during the performance of a working memory task in premutation carriers of the fragile X mental retardation 1 gene with and without fragile X-associated tremor/ataxia syndrome (FXTAS). Journal of Psychiatric Research 2011, 45(1):36-43.
70. Hashimoto R.-I., Javan A.K., Tassone F., Hagerman R.J., Rivera S.M. A voxel-based morphometry study of grey matter loss in fragile X-associated tremor/ataxia syndrome. Brain 2011, 134(Pt 3):863-878.
71. Hashimoto R.-I., Srivastava S., Tassone F., Hagerman R.J., Rivera S. Diffusion tensor imaging in male premutation carriers of the fragile X mental retardation gene. Movement Disorders 2011, 000(000):1-8.
72. Haut M.W., Kuwabara H., Leach S., Arias R.G. Neural activation during performance of number-letter sequencing. Applied Neuropsychology 2000, 7(4):237-242.
73. Hessl D., Wang J.M., Schneider A., Koldewyn K., Le L., Iwahashi C., et al. Decreased fragile X mental retardation protein expression underlies amygdala dysfunction in carriers of the fragile X premutation. Biological Psychiatry 2011, 70(9):859-865.
74. Hocking D.R., Kogan C.S., Cornish K.M. Selective spaital processing deficits in an at-risk subgroup of the fragile X premutation. Brain & Cognition 2012, 79(1):39-44.
75. Hoem G., Raske C.R., Garcia-Arocena D., Tassone F., Sanchez E., Ludwig A.L., et al. CGG-repeat length threshold for FMR1 RNA pathogenesis in a cellular model for FXTAS. Human Molecular Genetics 2011, 20(11):2161-2170.
76. Hoffman G.E., Le W.W., Entezam A., Otsuka N., Tong Z.-B., Nelson L., et al. Ovarian abnormalities in a mouse model of fragile X primary ovarian insufficiency. Journal of Histochemistry & Cytochemistry 2012, 60(6):439-456.
77. Hundscheid R.D., Braat D.D., Kiemeney L.A., Smits A.P., Thomas C.M. Increased serum FSH in female fragile X premutation carriers with either regular menstrual cycles or on oral contraceptives. Human Reproduction 2001, 16(3):457-462.
78. Hunsaker M.R., Goodrich-Hunsaker N.J., Willemsen R., Berman R.F. Temporal ordering deficits in female CGG KI mice heterozygous for the fragile X premutation. Behavioural Brain Research 2010, 213(2):263-268.
79. Hunsaker M.R., von Leden R.E., Ta B.T., et al. Motor deficits on a ladder rung task in male and female adolescent and adult CGG knock-in mice. Behavioural Brain Research 2011, 222:117-121.
80. Hunsaker M.R., Wenzel H.J., Willemsen R., Berman R.F. Progressive spatial processing deficits in a mouse model of the fragile X premutation. Behavioral Neuroscience 2009, 123(6):1315-1324.
81. Hunter J.E., Abramowitz A., Rusin M., Sherman S.L. Is there evidence for neuropsychological and neurobehavioral phenotypes among adults without FXTAS who carry the FMR1 premutation? A review of current literature. Genetics in Medicine 2009, 11(2):79-89.
82. Hunter J.E., Allen E.G., Abramowitz A., Rusin M., Leslie M., Novak G., et al. Investigation of phenotypes associated with mood and anxiety among male and female fragile X premutation carriers. Behavior Genetics 2008, 38(5):493-502.
83. Hunter J.E., Allen E.G., Abramowitz A., Rusin M., Leslie M., Novak G., et al. No evidence for a difference in neuropsychological profile among carriers and noncarriers of the FMR1 premutation in adults under the age of 50. American Journal of Human Genetics 2008, 83(6):692-702.
84. Hunter J.E., Rohr J.K., Sherman S.L. Co-occurring diagnoses among FMR1 premutation allele carriers. Clinical Genetics 2010, 77(4):374-381.
85. Hunter J.E., Epstein M.P., Tinker S.W., Abramowitz A., Sherman S.L. The FMR1 premutation and attention-deficit hyperactivity disorder (ADHD): evidence for a complex inheritance. Behvioural Genetics 2012, 42(3):415-422.
86. Hunter J.E., Sherman S.L., Grigsby J., Kogan C.S., Cornish K. Capturing the fragile X premutation phenotypes: a collaborative effort across multiple cohorts. Neuropsychologia 2012, 26(2):156-164.
87. Irwin S.A., Patel B., Idupulapati M., Harris J.B., Crisostomo R.A., Larsen B.P., et al. Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination. American Journal of Medical Genetics 2001, 98(2):161-167.
88. Ito M. Control of mental activities by internal models in the cerebellum. Nature Reviews Neuroscience 2008, 9(4):304-313.
89. Iwahashi C., Tassone F., Hagerman R.J., et al. A quantitative ELISA assay for the fragile x mental retardation 1 protein. The Journal of Molecular Diagnostics 2009, 11:281-289.
90. Iwahashi C.K., Yasui D.H., An H.J., Greco C.M., Tassone F., Nannen K., et al. Protein composition of the intranuclear inclusions of FXTAS. Brain 2006, 129(Pt 1):256-271.
91. Jacquemont S., Hagerman R.J., Hagerman P.J., Leehey M.A. Fragile-X syndrome and fragile X-associated tremor/ataxia syndrome: two faces of FMR1. Lancet Neurology 2007, 6(1):45-55.
92. Jacquemont S., Hagerman R.J., Leehey M.A., Hall D.A., Levine R.A., Brunberg J.A., et al. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. Journal of the American Medical Association 2004, 291(4):460-469.
93. Jakala P., Hanninen T., Ryynanen M., Laakso M., Partanen K., Mannermaa A., et al. Fragile-X: neuropsychological test performance, CGG triplet repeat lengths, and hippocampal volumes. Journal of Clinical Investigation 1997, 100(2):331-338.
94. Jin P., Duan R., Qurashi A., Qin Y., Tian D., Rosser T.C., et al. Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor/ataxia syndrome. Neuron 2007, 55(4):556-564.
95. Johnston C., Eliez S., Dyer-Friedman J., Hessl D., Glaser B., Blasey C., et al. Neurobehavioral phenotype in carriers of the fragile X premutation. American Journal of Medical Genetics 2001, 103(4):314-319.
96. Kamali A., Kramer L.A., Frye R.E., Butler I.J., Hasan K.M. Diffusion tensor tractography of the human brain cortico-ponto-cerebellar pathways: a quantitative preliminary study. Journal of Magnetic Resonance Imaging 2010, 32(4):809-817.
97. Keri S., Benedek G. Visual pathway deficit in female fragile X premutation carriers: a potential endophenotype. Brain & Cognition 2009, 69(2):291-295.
98. Keri S., Benedek G. The perception of biological and mechanical motion in female fragile X premutation carriers. Brain & Cognition 2010, 72(2):197-201.
99. Keri S., Benedek G. Fragile X protein expression is linked to visual functions in healthy male volunteers. Neuroscience 2011, 192:345-350.
100. Keri S., Benedek G. Why is vision impaired in fragile x premutation carriers? The role of fragile X mnetal retardation protein and potential FMR1 mRNA toxicity. Neuroscience 2012, 206:183-189.
101. Khalili K., Del Valle L., Muralidharan V., Gault W.J., Darbinian N., Otte J., et al. Puralpha is essential for postnatal brain development and developmentally coupled cellular proliferation as revealed by genetic inactivation in the mouse. Molecular & Cellular Biology 2003, 23(19):6857-6875.
102. Kogan C.S., Boutet I., Cornish K., Zangenehpour S., Mullen K.T., Holden J.J.A., et al. Differential impact of the FMR1 gene on visual processing in fragile X syndrome. Brain 2004, 127(Pt 3):591-601.
103. Kogan C.S., Bertone A., Cornish K., Boutet I., Der Kaloustian V.M., Andermann E., et al. Integrative cortical dysfunction and pervasive motion perception deficit in fragile X syndrome. Neurology 2004, 63(9):1634-1639.
104. Kogan C.S., Cornish K.M. Mapping self-reports of working memory deficits to executive dysfunction in fragile X mental retardation 1 (FMR1) gene premutation carriers asymptomatic for FXTAS. Brain & Cognition 2010, 73(3):236-243.
105. Koldewyn K., Hessl D., Adams J., Tassone F., Hagerman P.J., Hagerman R.J., et al. Reduced hippocampal activation during recall is associated with elevated FMR1 mRNA and psychiatric symptoms in men with the fragile X premutation. Brain Imaging and Behavior 2008, 2(2):106-116.
106. Kraan, C., Stolwyk, R., Testa, R. The abilities associated with verbal fluency performance in a young healthy population are multifactorial and differ across fluency variants. Applied Neuropsychology, in press.
107. Lachiewicz A., Dawson D., Spiridigliozzi G., Cuccaro M., Lachiewicz M., McConkie-Rosell A. Indicators of anxiety and depression in women with the fragile X premutation: assessment of a clinical sample. Journal of Intellectual Disability Research 2010, 54(7):597-610.
108. Lachiewicz A.M., Dawson D.V., Spiridigliozzi G.A., McConkie-Rosell A. Arithmetic difficulties in females with the fragile X premutation. American Journal of Medical Genetics. Part A 2006, 140(7):665-672.
109. Leehey M.A. Fragile X-associated tremor/ataxia syndrome: clinical phenotype, diagnosis, and treatment. Journal of Investigative Medicine 2009, 57(8):830-836.
110. Leehey M.A., Berry-Kravis E., Goetz C.G., Zhang L., Hall D.A., Li L., et al. FMR1 CGG repeat length predicts motor dysfunction in premutation carriers. Neurology 2008, 70(16 (Pt 2)):1397L 1402.
111. Leehey M.A., Berry-Kravis E., Min S.-J., Hall D.A., Rice C.D., Zhang L., et al. Progression of tremor and ataxia in male carriers of the FMR1 premutation. Movement Disorders 2007, 22(2):203-206.
112. Leung H.C., Skudlarski P., Gatenby J.C., Peterson B.S., Gore J.C. An event-related functional MRI study of the stroop color word interference task. Cerebral Cortex 2000, 10(6):552-560.
113. Lie C.-H., Specht K., Marshall J.C., Fink G.R. Using fMRI to decompose the neural processes underlying the Wisconsin card sorting test. Neuroimage 2006, 30(3):1038-1049.
114. Loesch D.Z., Bui Q.M., Dissanayake C., et al. Molecular and cognitive predictors of the continuum of autistic behaviours in fragile X. Neuroscience and Biobehavioral Review 2007, 31:315-326.
115. Loesch D.Z., Bui Q.M., Grigsby J., Butler E., Epstein J., Huggins R.M., et al. Effect of the fragile X status categories and the fragile X mental retardation protein levels on executive functioning in males and females with fragile X. Neuropsychology 2003, 17(4):646-657.
116. Loesch D.Z., Huggins R.M., Bui Q.M., Taylor A.K., Pratt C., Epstein J., et al. Effect of fragile X status categories and FMRP deficits on cognitive profiles estimated by robust pedigree analysis. American Journal of Medical Genetics. Part A 2003, 122A(1):13-23.
117. Loesch D.Z., Hay D.A., Mulley J. Transmitting males and carrier females in fragile X-revisited. American Journal of Medical Genetics 1994, 51(4):392-399.
118. Loesch D.Z., Kotschet K., Trost N., et al. White matter changes in basis pontis in small expansion FMR1 allele carriers with parkinsonism. American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics 2011, 156B:502-506.
119. Lu C., Lin L., Tan H., Wu H., Sherman S.L., Gao F., et al. Fragile X premutation RNA is sufficient to cause primary ovarian insufficiency in mice. Human Molecular Genetics 2012, 21(23):5039-5047.
120. Mazzocco M.M. Advances in research on the fragile X syndrome. Mental Retardation & Developmental Disabilities Research Reviews 2000, 6(2):96-106.
121. McCarthy A., Cuskelly M., van Kraayenoord C.E., Cohen J. Predictors of stress in mothers and fathers of children with fragile X syndrome. Research in Developmental Disabilities 2006, 27(6):688-704.
122. McConkie-Rosell A., Finucane B., Cronister A., Abrams L., Bennett R.L., Pettersen B.J. Genetic counseling for fragile x syndrome: updated recommendations of the national society of genetic counselors. Journal of Genetic Counseling 2005, 14:249-270.
123. Moore C.J., Daly E.M., Schmitz N., Tassone F., Tysoe C., Hagerman R.J., et al. A neuropsychological investigation of male premutation carriers of fragile X syndrome. Neuropsychologia 2004, 42(14):1934-1947.
124. Moore C.J., Daly E.M., Tassone F., Tysoe C., Schmitz N., Ng V., et al. The effect of pre-mutation of X chromosome CGG trinucleotide repeats on brain anatomy. Brain 2004, 127(Pt 12):2672-2681.
125. Morton S.M., Bastian A.J. Cerebellar control of balance and locomotion. Neuroscientist 2004, 10(3):247-259.
126. Morton S.M., Dordevic G.S., Bastian A.J. Cerebellar damage produces context-dependent deficits in control of leg dynamics during obstacle avoidance. Experimental Brain Research 2004, 156(2):149-163.
127. Murphy D.G., Mentis M.J., Pietrini P., Grady C.L., Moore C.J., Horwitz B., et al. Premutation female carriers of fragile X syndrome: a pilot study on brain anatomy and metabolism. Journal of the American Academy of Child & Adolescent Psychiatry 1999, 38(10):1294-1301.
128. Murray A. Premature ovarian failure and the FMR1 gene. Seminars in Reproductive Medicine 2000, 18(1):59-66. Review.
129. Murray A., Webb J., MacSwiney F., Shipley E.L., Morton N.E., Conway G.S. Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA premutation women. Human Reproduction 1999, 14(5):1217-1218.
130. Narcisa V., Aguilar D., Nguyen D.V., Campos L., Brodovsky J., White S., et al. A quantitative assessment of tremor and ataxia in female FMR1 premutation carriers using CATSYS. Current Gerontology and Geriatrics Research 2011, 146A(5):629-635.
131. Nathaniel-James D.A., Frith C.D. The role of the dorsolateral prefrontal cortex: evidence from the effects of contextual constraint in a sentence completion task. Neuroimage 2002, 16(4):1094-1102.
132. Nelson L.M. Clinical practice. Primary ovarian insufficiency. New England Journal of Medicine 2009, 360(6):606-614.
133. Nitschke M.F., Arp T., Stavrou G., Erdmann C., Heide W. The cerebellum in the cerebro-cerebellar network for the control of eye and hand movements-an fMRI study. Progress in Brain Research 2005, 148:151-164.
134. Ouchi Y., Okada H., Yoshikawa E., Nobezawa S., Futatsubashi M. Brain activation during maintenance of standing postures in humans. Brain 1999, 122(Pt 2):329L 338.
135. Papia M.F., Burke M.W., Zangenehpour S., Palmour R.M., Ervin F.R., Ptito M. Reduced soma size of the M-neurons in the lateral geniculate nucleus following foetal alcohol exposure in non-human primates. Experimental Brain Research 2010, 205(2):263-271.
136. Passamonti L., Novellino F., Cerasa A., Chiriaco C., Rocca F., Matina M.S., et al. Altered cortical-cerebellar circuits during verbal working memory in essential tremor. Brain 2011, 134(Pt 8):2274-2286.
137. Peprah E., He W., Allen E., Oliver T., Boyne A., Sherman S.L. Examination of FMR1 transcript and protein levels among 74 premutation carriers. Journal of Human Genetics 2010, 55(1):66-68.
138. Primerano B., Tassone F., Hagerman R.J., Hagerman P., Amaldi F., Bagni C. Reduced FMR1 mRNA translation efficiency in fragile X patients with premutations. Rna: A Publication of the Rna Society 2002, 8(12):1482-1488.
139. Qin M., Entezam A., Usdin K., et al. A mouse model of the fragile X premutation: effects on behavior, dendrite morphology, and regional rates of cerebral protein synthesis. Neurobiology of Disease 2011, 42:85-98.
140. Riddle J.E., Cheema A., Sobesky W.E., Gardner S.C., Taylor A.K., Pennington B.F., et al. Phenotypic involvement in females with the FMR1 gene mutation. American Journal of Mental Retardation 1998, 102(6):590-601.
141. Roberts J.E., Bailey D.B., Mankowski J., Ford A., Sideris J., Weisenfeld L.A., et al. Mood and anxiety disorders in females with the FMR1 premutation. American Journal of Medical Genetics. Part B. Neuropsychiatric Genetics: the Official Publication of the International Society of Psychiatric Genetics 2009, 150B(1):130-139.
142. Rodriguez-Revenga L., Madrigal I., Alegret M., Santos M., Mila M. Evidence of depressive symptoms in fragile-X syndrome premutated females. Psychiatric Genetics 2008, 18(4):153-155.
143. Rodriguez-Revenga L., Madrigal I., Badenas C., Xuncla M., Jimenez L., Mila M. Premature ovarian failure and fragile X female premutation carriers: no evidence for a skewed X-chromosome inactivation pattern. Menopause 2009, 16(5):944-949.
144. Rodriguez-Revenga L., Madrigal I., Pagonabarraga J., Xuncla M., Badenas C., Kulisevsky J., et al. Penetrance of FMR1 premutation associated pathologies in fragile X syndrome families. European Journal of Human Genetics 2009, 17(10):1359-1362.
145. Rodriguez-Revenga L., Pagonabarraga J., Gomez-Anson B., Lopez-Mourelo O., Madrigal I., Xuncla M., et al. Motor and mental dysfunction in mother-daughter transmitted FXTAS. Neurology 2010, 75(15):1370-1376.
146. Rohr J., Allen E.G., Charen K., Giles J., He W., Dominguez C., et al. Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study. Human Reproduction 2008, 23(5):1220-1225.
147. Sanchez-Cubillo I., Perianez J.A., Adrover-Roig D., Rodriguez-Sanchez J.M., Rios-Lago M., Tirapu J., et al. Construct validity of the trail making test: role of task-switching, working memory, inhibition/interference control, and visuomotor abilities. Journal of the International Neuropsychological Society 2009, 15(3):438-450.
148. Schmahmann J.D. Disorders of the cerebellum: ataxia, dysmetria of thought, and the cerebellar cognitive affective syndrome. Journal of Neuropsychiatry & Clinical Neurosciences 2004, 16(3):367-378.
149. Sellier C., Rau F., Liu Y., Tassone F., Hukema R.K., Gattoni R., et al. Sam68 sequestration and partial loss of function are associated with splicing alterations in FXTAS patients. EMBO Journal 2010, 29(7):1248-1261.
150. Seltzer M.M., Greenberg J.S., Hong J., Coe C., Almeida D. Differential sensitivity to life stress in FMR1 premutation carrier mothers of children with fragile X syndrome. Health Psychology 2011, 31(5):612-622.
151. Sherman S.L. Premature ovarian failure in the fragile X syndrome. American Journal of Medical Genetics 2000, 97(3):189-194.
152. Simon T.J. A new account of the neurocognitive foundations of impairments in space, time and number processing in children with chromosome 22q11.2 deletion syndrome. Developmental Disabilities Research Reviews 2008, 14(1):52-58.
153. Sobesky W.E., Hull C.E., Hagerman R.J. Symptoms of schizotypal personality disorder in fragile X women. Journal of the American Academy of Child & Adolescent Psychiatry 1994, 33(2):247-255.
154. Sobesky W.E., Taylor A.K., Pennington B.F., Bennetto L., Porter D., Riddle J., et al. Molecular/clinical correlations in females with fragile X. American Journal of Medical Genetics 1996, 64(2):340-345.
155. Sofola O.A., Jin P., Qin Y., Duan R., Liu H., de Haro M., et al. RNA-binding proteins hnRNP A2/B1 and CUGBP1 suppress fragile X CGG premutation repeat-induced neurodegeneration in a Drosophila model of FXTAS. Neuron 2007, 55(4):565-571.
156. Sokol D.K., Maloney B., Long J.M., Ray B., Lahiri D.K. Autism, Alzheimer disease, and fragile X: APP, FMRP, and mGluR5 are molecular links. Neurology 2011, 76(15):1344-1352.
157. Spath M.A., Feuth T.B., Allen E.G., Smits A.P.T., Yntema H.G., van Kessel A.G., et al. Intra-individual stability over time of standardized anti-Mullerian hormone in FMR1 premutation carriers. Human Reproduction 2011, 26(8):2185-2191.
158. Steyaert J., Borghgraef M., Fryns J.P. Apparently enhanced visual information processing in female fragile X carriers: preliminary findings. American Journal of Medical Genetics 1994, 51(4):374-377.
159. Stoodley C.J., Schmahmann J.D. Functional topography in the human cerebellum: a meta-analysis of neuroimaging studies. Neuroimage 2009, 44(2):489-501.
160. Stoodley C.J., Valera E.M., Schmahmann J.D. An fMRI study of intra-individual functional topography in the human cerebellum. Behavioural Neurology 2010, 23(1/2):65-79.
161. Strauss E., Sherman E.M.S., Spreen O. A Compendium of Neuropsychological Tests: Administration, Norms and Commentary 2006, New York, NY, US, Oxford University Press. 3rd ed.
162. Sullivan A.K., Marcus M., Epstein M.P., Allen E.G., Anido A.E., Paquin J.J., et al. Association of FMR1 repeat size with ovarian dysfunction. Human Reproduction 2005, 20(2):402-412.
163. Sullivan S.D., Welt C., Sherman S. FMR1 and the continuum of primary ovarian insufficiency. Seminars in Reproductive Medicine 2011, 29(4):299-307.
164. Tamburin S., Fiaschi A., Marani S., Andreoli A., Manganotti P., Zanette G. Enhanced intracortical inhibition in cerebellar patients. Journal of the Neurological Sciences 2004, 217(2):205-210.
165. Tan H., Li H., Jin P. RNA-mediated pathogenesis in fragile X-associated disorders. Neuroscience Letters 2009, 466(2):103-108.
166. Tassone F., Beilina A., Carosi C., et al. Elevated FMR1 mRNA in premutation carriers is due to increased transcription. RNA 2007, 13:555-562.
167. Tassone F., Greco C.M., Hunsaker M.R., Seritan A.L., Berman R.F., Gane L.W., et al. Neuropathological, clinical, and molecular pathology in female fragile X premutation carriers with and without FXTAS. Genes, Brain and Behavior 2012, 11(5):577-585.
168. Tassone F., Hagerman R. The fragile X-associated tremor ataxia syndrome. Results & Problems in Cell Differentiation 2012, 54:337-357.
169. Tassone F., Hagerman R.J., Garcia-Arocena D., Khandjian E.W., Greco C.M., Hagerman P.J. Intranuclear inclusions in neural cells with premutation alleles in fragile X associated tremor/ataxia syndrome. Journal of Medical Genetics 2004, 41(4):e43.
170. Tassone F., Hagerman R.J., Taylor A.K., Mills J.B., Harris S.W., Gane L.W., et al. Clinical involvement and protein expression in individuals with the FMR1 premutation. American Journal of Medical Genetics 2000, 91(2):144-152.
171. Till S.M. The developmental roles of FMRP. Biochemical Society Transactions 2010, 38(2):507-510. Review.
172. Uusisaari M., De Schutter E. The mysterious microcircuitry of the cerebellar nuclei. Journal of Physiology 2011, 589(14):3441-3457.
173. Van Dam D., Errijgers V., Kooy R.F., Willemsen R., Mientjes E., Oostra B.A., et al. Cognitive decline, neuromotor and behavioural disturbances in a mouse model for fragile-X-associated tremor/ataxia syndrome (FXTAS). Behavioural Brain Research 2005, 162(2):233-239.
174. Van der Molen M.J.W., Ridderinkhof K.R., Hamel B., Curfs L.M.G., Ramakers G.J.A. Attentional set-shifting in fragile X syndrome. Brain & Cognition 2012, 78(3):206-217.
175. Van der Molen M.J.W., Van der Molen M.W., Ridderinkhof K.R., Hamel B.C.J., Curfs L.M.G., Ramakers G.J.A. Auditory and visual cortical activity during selective attention in fragile X syndrome: a cascade of processing deficiencies. Clinical Neurophysiology 2012, 123(4):720-729.
176. Wang L.W., Berry-Kravis E., Hagerman R.J. Fragile X: leading the way for targeted treatments in autism. Neurotherapeutics 2010, 7(3):264-274.
177. Wang Y., Hessl D., Hagerman R., Tassone F., Rivera S.M. Age-dependent structural connectivity effects in fragile x premutation. Archive of Neurology 2012, 69(4):482-489.
178. Welt C.K., Smith P.C., Taylor A.E. Evidence of early ovarian aging in fragile X premutation carriers. Journal of Clinical Endocrinology & Metabolism 2004, 89(9):4569-4574.
179. Wenzel H.J., Hunsaker M.R., Greco C.M., Willemsen R., Berman R.F. Ubiquitin-positive intranuclear inclusions in neuronal and glial cells in a mouse model of the fragile X premutation. Brain Research 2010, 1318:155-166.
180. White M.K., Johnson E.M., Khalili K. Multiple roles for Puralpha in cellular and viral regulation. Cell Cycle 2009, 8(3):1-7.
181. Willemsen R., Hoogeveen-Westerveld M., Reis S., Holstege J., Severijnen L.-A.W.F.M., Nieuwenhuizen I.M., et al. The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ataxia syndrome. Human Molecular Genetics 2003, 12(9):949-959.
182. Willemsen R., Levenga J., Oostra B.A. CGG repeat in the FMR1 gene: size matters. Clinical Genetics 2011, 80(3):214-225.
183. Winarni T., Chonchaiya W., Sumekar T., Ashwood P., Morales G., Tassone F., et al. Immune-mediated disorders among women carriers of fragile X premutation alleles. American Journal of Medical Genetics 2012, 158A(10):2473-2481.
184. Wittenberger M.D., Hagerman R.J., Sherman S.L., McConkie-Rosell A., Welt C.K., Rebar R.W., et al. The FMR1 premutation and reproduction. Fertility & Sterility 2007, 87(3):456-465.
185. Zangenehpour S., Cornish K.M., Chaudhuri A. Whole-brain expression analysis of FMRP in adult monkey and its relationship to cognitive deficits in fragile X syndrome. Brain Research 2009, 1264:76-84.
186. Zhang L., Coffey S., Lua L.L., Greco C.M., Schafer J.A., Brunberg J., et al. FMR1 premutation in females diagnosed with multiple sclerosis. Journal of Neurology, Neurosurgery & Psychiatry 2009, 80(7):812-814.